IBD drugs Segars Flashcards
which ASA is used only for maintence therapy in UC
olsalazine
which a-4 integrin inhibtor is administered less often
vedolizumab
agents for UC categories
5-ASA (sala)
corticosteroids
TNF-a inhibtors (mab) (Golimumab)
a-4 integrin inhibitors (vedolizumab)
side effects of eluxadoline
GI related
hepatic/pancreatic toxicity
CNS related
alosetron indication
women with chronic, severe IBS-D not responsive to other conventional therapies
a-4 integrin inhibitors mechanism of action
limits integrin associated cell adhesion
loperamide MOA
for diarrhea
interferes with peristalsis by direct action on circular and longitudinal muscles of intestinal wall, slowing motility
-may also directly inhibit fluid and electrolyte secretion and or increase water absorption
side effects of alosetron
constipation
ischemic colitis
indications for a-4 integrin inhibitors
moderate to severe treatment resistant CD and UC and maintenance therapy to prevent relapse
uses of interleukin IL-12/23 inhibitors
moderate to severe treatment resistant CD (active and maintenance)
MOA for 5-ASAs
block COX and LIPOX which decreases PG and LT
uses of 5-ASA agents indications
mild to moderate active UC and maintenance of remission of UC
ustekinumab is what
MOA
interleukin IL-12/23 inhibitor
bind to specific subunit of IL-12/23 receptor located on surface of T cells and natural killer cells
-stops signal transduction and production of proinlfamm th1 and th17 cells
lubiprostone
activates specific CIC-2 chloride channels in luminal cells of intestinal epitheliumv = chloride rich intestinal fluid secretion
- prostaglandin E-1 derivative
- lube up the intestine
which of the 5-ASAs has 2 molecules of 5-ASA
olsalazine